March 3, 2022 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
March 3, 2022 Comments Off on New patent expiration for Noden Pharma drug TEKTURNA HCT Posted in: Uncategorized
Annual Drug Patent Expirations for TEKTURNA+HCT Tekturna Hct is a drug marketed by Noden Pharma and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Noden Pharma drug TEKTURNA HCT appeared fir…
